Laser Skin Resurfacing & Treatment Systems
Ablative and non-ablative laser platforms treating wrinkles, scars, pigmentation, and vascular lesions in dermatology and medical aesthetics practice settings.
Market snapshot
These figures describe Aesthetic & Dermatology Energy Devices (4.8.1), the segment that Laser Skin Resurfacing & Treatment Systems sits within — not Laser Skin Resurfacing & Treatment Systems on its own.
Within electromedical apparatus (NAICS 334510); the Census Bureau does not split out aesthetic energy devices, so the segment is not separately sized.
Business model & economics
Revenue model
Capital devices plus recurring consumables and service
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 15–28%
- Capex intensity
- High
consumables and service revenue
Characteristics
- Tied to the booming medical-aesthetics market.
- Med-spa expansion drives device demand.
- Capital devices plus recurring consumables.
Geographic concentration
Aesthetic and dermatology energy-device makers cluster in Massachusetts and California, the photonics and medical-device engineering centers behind laser and energy-based platforms.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 334510. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Aesthetic-device strategics
- Medtech & pharma aesthetics platforms
- PE-backed device companies
What’s driving deals
- Medical-aesthetics market growth.
- Med-spa and procedure expansion.
- Discretionary aesthetic-spending sensitivity.
Find Laser Skin Resurfacing & Treatment Systems acquisition targets
Search Acquisera’s index for companies classified under Laser Skin Resurfacing & Treatment Systems (4.8.1.3) and build a targeted deal pipeline.
Search companies